Atrial arrhythmias in long-QT syndrome under daily life conditions: A nested case control study

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 4, 2009, Pages 401-407

  Zellerhoff, Stephan ^a   Pistulli, Rudin ^a   Mönnig, Gerold ^a   Hinterseer, Martin ^d   Beckmann, Britt Maria ^d   Köbe, Julia ^a   Steinbeck, Gerhard ^c,d   Kääb, Stefan ^c,d   Haverkamp, Wilhelm ^f   Fabritz, Larissa ^a,b   Gradaus, Rainer ^a   Breithardt, Günter ^a,c   Schulze Bahr, Eric ^a,b,e   Böcker, Dirk ^a   Kirchhof, Paulus ^a,b,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research   (Germany)

^c German Atrial Fibrillation Competence NETwork (AFNET)   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e Leibniz Institute for Arteriosclerosis Research   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Action potential; Atrial fibrillation; Clinical study; Long QT syndrome; Torsades de pointes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEFIBRILLATOR; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; TREATMENT DURATION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHILD; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63049105169     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01339.x     Document Type: Article

References (33)

1. Moss AJ : Long QT syndrome. JAMA 2003 289 : 2041 2044.
2. Lehnart SE, Ackerman MJ, Benson DW Jr., Brugada R, Clancy CE, Donahue JK, George AL Jr., Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR : Inherited arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007 116 : 2325 2345.
3. Nattel S : Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management? Cardiovasc Res 2002 54 : 347 360.
4. Kirchhof P, Eckardt L, Franz MR, Monnig G, Loh P, Wedekind H, Schulze-Bahr E, Breithardt G, Haverkamp W : Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome. J Cardiovasc Electrophysiol 2003 14 : 1027 1033.
5. Kirchhof P, Eckardt L, Monnig G, Johna R, Loh P, Schulze-Bahr E, Breithardt G, Borggrefe M, Haverkamp W : A patient with "atrial torsades de pointes." J Cardiovasc Electrophysiol 2000 11 : 806 811.
6. Satoh T, Zipes DP : Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: Atrial torsades de pointes? J Cardiovasc Electrophysiol 1998 9 : 970 975.
7. Sinner MF, Pfeufer A, Akyol M, Beckmann BM, Hinterseer M, Wacker A, Jalilzadeh S, Sauter W, Näbauer M, Wichmann H-E, Meitinger T, Kääb S : Der Polymorphismus KCNH2-K897T ist signifikant mit Vorhofflimmern assoziiert: Ergebnisse einer großen, mehrstufigen, Linkage-Disequilibrium-basierten Untersuchung. Spring Meeting of the German Society of Cardiology 2007.
8. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R, Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J, Chen Y : Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004 75 : 899 905.
9. Ehrlich JR, Zicha S, Coutu P, Hebert TE, Nattel S : Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. Cardiovasc Res 2005 67 : 520 528.
10. Chen LY, Ballew JD, Herron KJ, Rodeheffer RJ, Olson TM : A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 2007 81 : 35 41.
11. Vincent GM : Atrial arrhythmias in the inherited long QT syndrome: Laboratory quirk or clinical arrhythmia? J Cardiovasc Electrophysiol 2003 14 : 1034 1035.
12. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004 43 : 47 52.
13. Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G : Prevention of atrial fibrillation after cardioversion: Results of the PAFAC trial. Eur Heart J 2004 25 : 1385 1394.
14. Patten M, Maas R, Bauer P, Luderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Muller HW, Meinertz T : Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial. Eur Heart J 2004 25 : 1395 1404.
15. Ziegler PD, Koehler JL, Mehra R : Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006 3 : 1445 1452.
16. de Voogt WG, van Hemel NM, van de Bos AA, Koistinen J, Fast JH : Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording. Europace 2006 8 : 950 961.
17. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G : Outcome parameters for trials in atrial fibrillation: Executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007 28 : 2803 2817.
18. Monnig G, Kobe J, Loher A, Eckardt L, Wedekind H, Scheld HH, Haverkamp W, Milberg P, Breithardt G, Schulze-Bahr E, Bocker D : Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-up. Heart Rhythm 2005 2 : 497 504.
19. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ : Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001 285 : 2864 2870.
20. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M : Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003 14 : 337 341.
21. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML : Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000 101 : 616 623.
22. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D : Risk stratification in the long-QT syndrome. N Engl J Med 2003 348 : 1866 1874.
23. Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W : Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol 2005 10 : 67 83.
24. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE : Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001 285 : 2370 2375.
25. Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, Berul CI : Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001 12 : 1097 1101.
26. Stefanelli CB, Bradley DJ, Leroy S, Dick M, 2nd., Serwer GA, Fischbach PS : Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002 6 : 235 244.
27. Gradaus R, Wollmann C, Kobe J, Hammel D, Kotthoff S, Block M, Breithardt G, Bocker D : Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart 2004 90 : 328 329.
28. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J : Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996 78 : 703 706.
29. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI : A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006 17 : 41 46.
30. Ten Harkel AD, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MT : Implantable cardioverter defibrillator implantation in children in The Netherlands. Eur J Pediatr 2005 164 : 436 441.
31. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, George AL Jr., Roden DM : Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008 117 : 1927 1935.
32. Johnson JN, Tester DJ, Perry J, Salisbury BA, Reed CR, Ackerman MJ : Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm 2008 5 : 704 709.
33. Chatrath R, Porter CB, Ackerman MJ : Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc 2002 77 : 226 231.